VIVO VENTURES VII, LLC Insider Trading Activity

Average Profitability
71.55%
Insider Buys Quantity
2
Insider Buys Sum
$10.29M
Insider Sells Quantity
21
Insider Sells Sum
$92.67M

Insider Activity of VIVO VENTURES VII, LLC

Biography of VIVO VENTURES VII, LLC

No biography is available at this moment.

2017-03-02SaleAclaris Therapeutics, Inc.
ACRS
10 percent owner
250,000
0.9707%
$31.20$7.8M-16.52%
2017-03-01SaleAclaris Therapeutics, Inc.
ACRS
10 percent owner
200,000
0.7605%
$30.98$6.2M-17.61%
2017-02-28SaleAclaris Therapeutics, Inc.
ACRS
10 percent owner
400,000
1.4978%
$30.50$12.2M-17.53%
2016-11-18SaleAclaris Therapeutics, Inc.
ACRS
10 percent owner
900,000
3.3649%
$22.72$20.45M+4.46%
2016-11-16SaleAclaris Therapeutics, Inc.
ACRS
10 percent owner
915,656
3.9962%
$23.34$21.37M+18.68%
2016-09-08SaleCodexis, Inc.
CDXS
10 percent owner
223,200
0.5655%
$4.25$949,247+13.41%
2016-08-16SaleCodexis, Inc.
CDXS
10 percent owner
73,788
0.1832%
$4.21$310,441+11.11%
2016-08-15SaleCodexis, Inc.
CDXS
10 percent owner
100,000
0.2486%
$4.27$427,400+9.52%
2016-08-04SaleCodexis, Inc.
CDXS
10 percent owner
100,000
0.2448%
$4.17$416,840+10.58%
2016-08-03SaleCodexis, Inc.
CDXS
10 percent owner
60,000
0.1458%
$4.30$257,898+5.9%
2015-10-13PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
909,090
4.5006%
$11.00$10M+61.56%
2015-10-07PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
26,704
0.1491%
$11.00$293,744+81.54%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.